Products

Phragmitis Rhizoma Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions

    • Product Name: Phragmitis Rhizoma Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions
    • Alias: Lugen Vet
    • Einecs: 310-127-6
    • Mininmum Order: 1 g
    • Factroy Site: Yudu County, Ganzhou, Jiangxi, China
    • Price Inquiry: admin@ascent-chem.com
    • Manufacturer: Ascent Petrochem Holdings Co., Limited
    • CONTACT NOW
    Specifications

    HS Code

    585176

    Product Name Phragmitis Rhizoma Veterinary Grade API
    Common Names Common Reed Rhizome, Lugen
    Appearance Light brown to yellowish powder
    Source Dried rhizome of Phragmites australis
    Intended Use Active Pharmaceutical Ingredient for veterinary tablets, injections, capsules, powders, granules, premix, and solutions
    Solubility Partially soluble in water, insoluble in most organic solvents
    Purity ≥98% (by HPLC)
    Storage Conditions Store in cool, dry place away from light
    Shelf Life 24 months if properly stored
    Molecular Formula Varies (mixture of glycosides and polysaccharides)
    Primary Functions Anti-inflammatory, diuretic, antipyretic, expectorant
    Manufacturing Standard Complies with veterinary GMP standards
    Package Options 1kg/aluminum foil bag, 25kg/drum
    Country Of Origin China

    As an accredited Phragmitis Rhizoma Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing Sealed 25kg fiber drums with double-layer PE linings; external labeling includes “Phragmitis Rhizoma Veterinary Grade API,” batch, quantity, and manufacturer.
    Shipping The Phragmitis Rhizoma Veterinary Grade API ships in secure, tamper-proof packaging suitable for tablets, injections, capsules, powders, granules, premix, and solutions. Each container is clearly labeled, moisture-protected, and conforms to international standards, ensuring stability and integrity during transit. Expedited or temperature-controlled shipping is available upon request.
    Storage Phragmitis Rhizoma Veterinary Grade API should be stored in a tightly sealed container, protected from light and moisture, under cool and dry conditions (ideally below 25°C). Store in a well-ventilated area away from incompatible substances. Ensure proper labeling and restrict access to authorized personnel only, following relevant regulations to maintain product integrity for use in tablets, injections, capsules, powders, granules, premix, or solutions.
    Application of Phragmitis Rhizoma Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions

    Applications of Phragmitis Rhizoma Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions in Industrial Manufacturing

    Phragmitis Rhizoma Veterinary Grade API functions as a key traditional herbal component in diverse veterinary medicine preparations. Our manufacturing expertise supports high-volume, process-controlled production for pharmaceutical-grade animal health applications meeting global industry requirements. Below, we detail actual downstream scenarios where this ingredient delivers measurable formulation and process value.

    1. Veterinary Oral Tablets for Livestock Respiratory Support

    Large animal pharmaceutical manufacturers formulate Phragmitis Rhizoma Veterinary Grade API into compressed tablets designed to support respiratory health in cattle, swine, and small ruminants. The material is used for its specific soothing and clearing properties, in line with monographs and validated by QC protocols for consistency in each batch. The tableting process integrates the API with functional excipients under controlled blending and compaction operations, ensuring homogeneity and bioavailability upon oral administration.

    Industry compliance standards

    • Chinese Veterinary Pharmacopoeia (CVP) monograph requirements
    • Good Manufacturing Practice (GMP) for Veterinary Medicinal Products (EU and China GMP)
    • Veterinary Drugs Administration Regulations (China MOA)
    • ISO 9001:2015 certified quality systems

    Typical usage ratio

    • 5–15% w/w of total tablet mass, adjusted based on targeted daily dose for the animal species, potency of raw material batch, and tablet size

    Downstream process integration

    • Dry blending with functional excipients prior to granulation
    • Direct compression into tablets
    • Inclusion in coating solutions for modified-release profiles (if applicable)
    • Release testing fully aligned to CVP content requirements

    Final product types

    • Coated and uncoated veterinary oral tablets for cattle, sheep, goats, and pigs
    • Bolus forms for ruminants

    2. Injectable Formulations for Companion Animal Support

    Animal health solution manufacturers apply Phragmitis Rhizoma API in sterile injectable preparations for dogs, cats, and equines. The process involves precise extraction and micronization to achieve sterility and solubility parameters, meeting injectable-grade standards. The API’s anti-inflammatory and respiratory soothing functions are leveraged in veterinary clinics, subject to batch record traceability and solution clarity specifications.

    Industry compliance standards

    • Chinese Veterinary Pharmacopoeia (CVP) Injection Preparation Standards
    • European Pharmacopoeia Chapter 1 for Veterinary Injections
    • Veterinary Drug GMP (China and EU/US equivalents)
    • Sterility Testing per Pharmacopeial Methodologies (USP <71>, EP 2.6.1)

    Typical usage ratio

    • Concentration of 10–40 mg/mL in aqueous or buffered injectable solution, set according to species indication and pharmacokinetic considerations

    Downstream process integration

    • Dissolution into sterile solvent post-filtration
    • Aseptic filling into single- or multi-dose vials
    • Terminal sterilization or sterile filtration prior to packaging
    • QA review focusing on solution clarity and API assay validation

    Final product types

    • Veterinary injectable vials for clinics and farm use
    • Pre-filled syringes for equine and companion animal care

    3. Herbal Veterinary Powders for Feed Supplementation

    Feed additive and supplement producers integrate Phragmitis Rhizoma API into free-flowing powder blends aimed at large-herd antibiotic-free protocols. This route targets the mixing of the API with compatible carriers and other feed-grade herbs, ready for direct admixture into animal feeds or use as standalone water-soluble supplements. Focus remains on uniform API dispersion and stability throughout logistics and downstream reconstitution.

    Industry compliance standards

    • Feed Additive Registration Guidelines (China MOA, EU Regulation EC No 1831/2003)
    • Veterinary Herbal Product GMP
    • ISO 22000:2018 Food Safety Management Systems
    • FAMI-QS for feed ingredient supply chain

    Typical usage ratio

    • 0.1–2.5% inclusion rate w/w in complete feed, determined by species, growth phase, and regional additive limits

    Downstream process integration

    • Pre-mixing with carrier base (corn starch, rice hulls)
    • Blending with micro-ingredients before macro ingredient addition
    • Sieving and packaging to minimize segregation
    • Lab confirmation of component uniformity and stability

    Final product types

    • Water-soluble veterinary powder pouches
    • Direct-to-feed particulate powders for ruminants, swine, and poultry

    4. Veterinary Granule Preparations for Flexible Dosing

    Animal pharmaceutical processing lines use Phragmitis Rhizoma API for granule forms which allow for flexible oral dosing and palatability improvement. Precision wet granulation and controlled drying assure uniform distribution and bioavailability, meeting granulated product standards for dissolution and flowability required in bulk veterinary use. Quality systems monitor granule size, content uniformity, and expiration dating as required by regulatory export markets.

    Industry compliance standards

    • Veterinary Granule Product Standards (Chinese Pharmacopoeia, applicable regional directives)
    • Veterinary Medicinal Product Registration (China/CVP, EU VMP)
    • ICH Q6A specifications for finished product uniformity
    • ISO 9001/14001 quality-environmental system for granulation plants

    Typical usage ratio

    • 3–12% w/w of finished granule batch, tuned by desired dosing regimen and final granule mass

    Downstream process integration

    • Wet granulation with binders and excipients
    • Controlled drying and sieving for granule size range adherence
    • Bulk bin packaging or sachet filling
    • Routine sampling for stability and purity verification

    Final product types

    • Multi-dose veterinary granule packets for farm and veterinary clinic use
    • Single-dose sachets for targeted animal application

    5. Veterinary Combination Premixes for Large-Scale Feed Mills

    Industrial premix compounding facilities blend Phragmitis Rhizoma API with vitamins, minerals, and other permitted herbal extracts to produce veterinary premix concentrates. These intermediates undergo standardized blending and robust QC before being incorporated into compound feed for swine, poultry, and ruminants. Batch documentation ensures traceability and compliance with compound feed medication regulations, essential for large-scale operations.

    Industry compliance standards

    • Feed Premix Standards (China MOA, EU EFSA guidelines, US FDA CFR Title 21)
    • Good Manufacturing Practice (GMP) for feed and additives
    • Feed Hygiene Regulation (EC) No 183/2005
    • HACCP and ISO 22000 Food Safety Systems

    Typical usage ratio

    • 0.5–3% of total premix batch; further diluted on-farm to reach effective API delivery levels in complete feed, adjusted per veterinarian direction and feed intake patterns

    Downstream process integration

    • Dry blending with flow agents and micro-ingredients
    • Uniformity testing for batch acceptance
    • Bulk packaging for transport to professional feed mills
    • End-user addition into compound feed during final feed mixing

    Final product types

    • Premixed veterinary additive powders for inclusion at industrial feed production facilities
    • Custom formulation blends for contract feed milling

    6. Veterinary Capsule Manufacturing for Small and Exotic Animals

    Phragmitis Rhizoma API is used by veterinary pharmaceutical manufacturers to formulate capsules suitable for individualized dosing in small animals and exotics. The process requires micro-milling to achieve uniform particle size for capsule filling, while ingredient compatibility checks ensure no cross-reactivity with capsule shells or inert fillers. Final QC includes capsule strength, disintegration, and content uniformity to meet monograph standards.

    Industry compliance standards

    • Veterinary Capsule Preparation Standards (Chinese Veterinary Pharmacopoeia, EU VMP guidelines)
    • GMP for Veterinary Drugs (China/Europe/US)
    • ICH Q8 Pharmaceutical Development framework
    • ISO 9001:2015 pharmaceutical manufacturing certification

    Typical usage ratio

    • 20–150 mg API per capsule, determined by animal weight, treatment duration, and capsule size (size 1–4)

    Downstream process integration

    • Grinding and micronization prior to blending
    • Dry pre-mixing with compatible fillers and flow regulators
    • Automated capsule filling and sealing
    • Lot release testing for disintegration and content accuracy

    Final product types

    • Veterinary capsules for individualized dosing in dogs, cats, rabbits, and exotic pets
    • Multi-capsule dosages for veterinary clinical practice

    7. Liquid Veterinary Solutions for Poultry Dosing

    Veterinary solution manufacturing plants use Phragmitis Rhizoma API in aqueous oral solution forms for ease of dosing via poultry drinking systems. The formulation sequence ensures solubility, flavor masking, and sedimentation stability throughout shelf life. Process flow prioritizes fluid filtration, homogenization, and preservative dosing to ensure the finished solution meets physical, chemical, and microbiological release limits.

    Industry compliance standards

    • Veterinary Oral Solution Registration (Chinese Veterinary Pharmacopoeia, EU VMP, US FDA animal health)
    • GMP for Liquid Preparation (ISO 22716, China/Europe/US)
    • Conducted in facilities with water for pharmaceutical use (WPU) compliance
    • Batch release based on finished product monograph limits

    Typical usage ratio

    • 250–800 mg API per liter of finished solution, adjusted by flock size and species to achieve the desired effective daily intake through water supply

    Downstream process integration

    • Dissolving API in water with solubilizers and stabilizers at controlled temperatures
    • Homogenizing to achieve sediment-free solutions
    • Sterile filtration prior to final filling
    • Filling into bulk or single-use bottles for field distribution

    Final product types

    • Large volume oral veterinary solutions for poultry operations
    • Measured-dose bottles for on-farm administration

    Free Quote

    Competitive Phragmitis Rhizoma Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please contact us at +8615365186327 or mail to admin@ascent-chem.com.

    We will respond to you as soon as possible.

    Tel: +8615365186327

    Email: admin@ascent-chem.com

    Get Free Quote of Ascent Petrochem Holdings Co., Limited

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    Phragmitis Rhizoma Veterinary Grade API: Supporting Animal Health with Proven Botanical Solutions

    Understanding the Role of Phragmitis Rhizoma in Modern Veterinary Formulations

    Years of hands-on practice in the chemical manufacturing space show that finding robust active pharmaceutical ingredients (APIs) with a track record means fewer headaches for veterinarians and producers alike. Our Phragmitis Rhizoma veterinary grade API comes from a direct and steady production process, rooted in controlled cultivation and rigorous extraction methods. Nobody in the supply chain values consistency more than the team crafting the material from plant to powder. By keeping the process transparent, we've avoided the pitfalls of variable quality and uncertain sourcing that commonly undermine herbal product reliability.

    The plant at the heart of this API, Phragmitis rhizome, has seen centuries of use in animal and human medicine throughout East Asia. We have learned from history while applying our expertise to modern safety and purity demands. After all, in the API industry, nothing beats rigorous testing and validation through each step of processing. Bringing this raw botanical into veterinary applications calls for more than tradition. It calls for a factory team attentive to residue, ash, heavy metal content, and microbial limits—because these directly shape end-user experience for veterinarians and livestock producers.

    Differentiation: How Veterinary Grade Phragmitis Rhizoma API Stands Out

    Plenty of herbal APIs circulate in the market, often looking the same at first glance. Behind the scenes, real differences add up fast. Our Phragmitis rhizome API purposely exceeds the basic standards for food or human supplements. This translates into cleaner, more predictable batches every shipment, batch-tested for critical components like saponins, polysaccharides, and flavonoids, along with careful screening for pesticide residues. By focusing on what actually matters to veterinarians—visible clarity, solubility, tight limits on potentially harmful byproducts—we steer clear of superficial claims and put value into measurable performance.

    Veterinary grade preparation demands more than a COA (certificate of analysis) and a pretty product sample. The volatility in plant source, seasonal harvesting, and processing parameters can throw off alkaloid or saponin profiles. We tightly control these variables by sourcing rhizomes from managed growing areas, processing them in climate-controlled facilities, and maintaining standard drying and grinding parameters. Each batch undergoes authenticated botanical identification coupled with multi-marker ingredient quantification, giving formulators what they need: consistency from month to month, and year to year.

    Model, Specifications, and Suitability for Dosage Forms

    Our Phragmitis Rhizoma veterinary API comes in several controlled particle size distributions, tailored for the needs of tablets, capsules, premixes, granules, oral solutions, and injectables. These grades serve the different manufacturing environments our partners operate in—from high-shear mixers on large volume pellet lines to finer dispersions for solution or injectable suspension forms. By offering specific mesh cuts and ready-suspensible powders, formulation teams save on wet milling and reduce downstream processing headaches. Real-world experience shows that investing in a spec-exact product brings down total preparation costs in the long term.

    The veterinary API, built for precise dosing and rapid dispersion, addresses key product characteristics: moisture content, pH stability, and color retention. Most tablets and capsules require a free-flowing, non-cohesive powder; granules and premixes prioritize blendability and long-term storage stability. We keep unwanted binders, fillers, and extraneous materials out, offering a single-ingredient API—pure, traceable, and guaranteed free from cross-contamination that could compromise target species.

    Reliability Under Scrutiny: Meeting Veterinary Safety and Efficacy Expectations

    Animal health products operate under a different scrutiny than standard feed or supplement markets. Adherence to country-specific veterinary standards—a subject too often skirted by traders—remains central in our workflow. Years of third-party validation, batch archiving, and traceability have shown that veterinarians trust only what can be demonstrated. Stability data under standard animal health storage conditions, long-duration antimicrobial residue testing, and extended shelf life trials form the backbone of our continuous output.

    During scale-up from pilot to production, we noticed that poorly controlled botanical APIs tended to clog tablet presses or create inconsistent suspensions. These were pain points for our end users—wasted labor, irregular dosing, reprocessing. Our technical teams work with customers during the initial formulation phase to match API grade with specific tooling and binder systems, minimizing process losses. A tablet or premix batch that sails through QA testing on the first try saves time, money, and client trust.

    Batch Control and Traceability

    Drawing from the decades spent refining our manufacturing and QA/QC systems, every Phragmitis Rhizoma veterinary API batch is tracked from seedling plot to finished drum. Backward traceability links every bag of raw material to a GPS-located farm parcel and harvest year. The move to digital tracking means that clients receive not just a printed certificate, but a secure online record, with links to in-house and third-party assay results.

    Plant-based APIs often face questions around adulteration or substitution—a risk amplified by globalized sourcing. Our answer lies in transparent supply chains and willingness to open our records for regulatory or partner examination. Each drum ships with direct-to-lot source data. It brings peace of mind to partners in highly regulated environments, and builds the reputation of our brand, not only in product reliability, but also in accountability.

    Usage Scenarios: Formulation and Compliance in Action

    Veterinary practitioners and pharmaceutical preparers expect clear fit-for-use guidance. Our Phragmitis Rhizoma API supports a wide range of delivery forms: direct blending into complete feeds as a powder, high-load tablet pressing, microencapsulated granule formation, and as a solubilized concentrate for oral solutions and injectable products. Each of these modes brings a separate set of technical hurdles—granule friability, suspension stability, tablet hardness, and solution clarity. Working with hundreds of customers navigating these challenges has shaped our approach: less about minimizing costs per kilo, more about supporting smooth processing and reliable performance post-distribution.

    Animal species differences, dietary context, and regional rules often change how these APIs can be combined or claimed. Some partners in regions with strict veterinary oversight use Phragmitis Rhizoma mainly for formulation prototypes and registered medicinal premixes; others in less regulated markets incorporate it right into self-produced feed blends or compounded injectables. Our internal advisory team helps clarify which batch grade interfaces best with a given formulation, and shares practical dosing benchmarks observed from commercial use.

    Quality Markers and Their Real Impact on Animal Health Products

    The veterinary world thrives on results, not promises. Whether the end user is a dairy processor, livestock cooperative, or practicing veterinarian, their expectations all boil down to practical, measurable performance. Phragmitis Rhizoma’s main saponins, flavonoids, and polysaccharides have published pharmacological data supporting use for fever control, diuresis, and gastrointestinal management in several livestock species. Still, the leap from promising paper to real animal improvement comes down to reliable, batch-stable raw materials.

    Repeated feedback from our clients confirms what science journals hint at: subtle shifts in active content or bioburden levels can swing animal outcomes. Premix producers testing for saponin content or heavy metal presence now expect every drum—or even every sub-batch—to report these figures upfront, not on request. Our investment in on-site HPLC and microbial load facilities pays off in tight control over the product entering a medicine or supplement line, helping downstream users stay rooted in compliance.

    Facing Regulatory and Industry Pressures Head-On

    The veterinary chemical space faces ever-tightening scrutiny, with regulations demanding tougher limits on contaminants and clearer documentation around active ingredient content. Failing to keep pace means risking costly product recalls or loss of market access. By building our process documentation, validation studies, and supply chain traceability into each batch, we not only anticipate these shifts, but help our clients prepare for audits with confidence.

    International expansion presents fresh hurdles. Variability in allowable residual solvents or extraction aids, discrepancies in botanical identification requirements, and mounting pressure for cleaner, pesticide-free APIs challenge every manufacturer. Long before regulators called for it, we implemented processing steps to remove residual azoles, conserve marker flavonoids, and screen for a broad spectrum of pesticides. Our willingness to reformulate or re-test to help a client attain local compliance signals our place as committed manufacturers, not just component providers.

    Lessons from the Field: End-User Experience Shapes Production

    Feedback from the end of the supply chain—especially farm managers and veterinary doctors—often proves more valuable than lab data alone. Over the years, we have responded to complaints around caking, off-odor, or rapid discoloration by revisiting drying and milling parameters. Clear, practical feedback from powder blending failures or storage instability in the tropics shaped upgrades in our dehumidification and bulk packaging protocols.

    Local realities, such as delivery time in humid conditions or repeated exposure to high heat in transport vehicles, show up as product failures if not anticipated upstream. Our technical teams have traveled with veterinarians on farm callouts, watched livestock caretakers try to blend premixes with gloved hands, and witnessed first-hand the limitations of real-world dosing, from sweltering barns to large-scale broiler houses. These on-the-ground observations directly feed back into our product development and shipping standards.

    Developing for Tomorrow: Sustainability in Supply and Production

    Growing and processing Phragmitis Rhizoma at a scale fit for the veterinary market puts fresh demands on sustainable agriculture and manufacturing. Our fields run on controlled water use, integrated pest management, and annual soil testing. Unlike wildcrafted materials prone to adulteration and ecological damage, our contract farmers follow transparent guidelines, checked through yearly audits. Supporting sustainable rhizome production isn’t just a branding exercise; it assures a stable API supply for veterinarians and animal health product makers years down the road.

    Resource management extends beyond raw materials. Reducing waste streams during extraction, recapturing process water, and using low-residual solvents mean compliance with rising environmental restrictions in major export regions. These steps do not simply tick boxes for sustainability audits; they reduce long-term risk throughout the supply chain and help our partners maintain their certifications and market access, even as sustainability standards tighten.

    Continual Improvement: Staying Aligned with Animal Health Needs

    The path from the original Phragmitis rhizome to a functional veterinary API runs on both discipline and adaptation. By keeping one eye on regulatory evolution and another on farm-level performance, we've built a feedback-driven, continuously improving process. Involving both plant agronomists and end-user veterinarians in our advisory panel grounds each new process upgrade in the hands-on needs of those who use or prescribe these APIs daily.

    Market demand doesn’t come from manufacturers or regulators—it comes from the daily needs of livestock, companion animals, and the people who care for them. Staying open to making small changes in drying time, particle sizing, or storage parameters based on actual field experience means our Phragmitis Rhizoma API adapts to changing dietary formula requirements or emerging animal health trends. Innovations don’t always come from the lab; often, the best upgrades evolve from seeing firsthand how a batch handles in a cold barn, busy feed plant, or during practical veterinary rounds.

    Practical Support and Field Partnership: More than API in a Drum

    Manufacturers with years in the sector know supply isn’t just about getting an API out the factory gates. We’ve sat alongside veterinary developers auditing our facilities, run co-validation trials for new oral dispersible formulations, and gone through the headaches of regulatory review hand-in-hand with animal health partners. Each tough question leads to another improvement—be it tighter product labeling for veterinarian use, expanded in-process controls for cross-contamination risks, or additional environmental certifications for export to Europe and the Americas.

    Sharing data, opening the doors to production lines, and accepting third-party auditors became second nature to our team. Instead of bristling at new compliance hurdles, we take each one as a challenge to sharpen our systems. Whether the request comes from a poultry hatchery looking for improved immune support or a cattle feedlot aiming for residue-free production, open channels for real feedback and rapid testing are our strongest tools.

    Conclusion: Real-World Commitment Shows in Every Batch

    Our commitment to veterinary-grade Phragmitis Rhizoma runs deeper than meeting minimum specs. From controlled cultivation through to batch-tested, traceable, and clean API production, we believe in strengthening every link between the raw plant and the animal health practitioner. Growing demands around quality markers, residue safety, and consistent sourcing push us to keep improving, see the world through both the manufacturer’s and the veterinarian’s eyes, and never settle for good enough. These standards, grounded in experience and built on a tradition of partnership, keep our API ahead of shifting market expectations and give confidence to those feeding, treating, and caring for animals around the globe.

    Top